Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
First-in-Human Phase I Study of Minnelide in Patients With Advanced Gastrointestinal Cancers: Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity.
Journal: The oncologist
Published: October 23, 2022
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 16, 2017
Low-dose whole brain radiotherapy combined with radiosurgery for primary CNS lymphoma achieving partial response to induction methotrexate-based chemotherapy.
Journal: Journal of radiosurgery and SBRT
Published: January 01, 2014
Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: March 16, 2013
Non-Hodgkin's lymphomas, version 1.2013.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 15, 2013
A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma.
Journal: Cancer investigation
Published: February 15, 2013
Non-Hodgkin's Lymphomas, version 3.2012.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: December 11, 2012
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.
Journal: Cancer medicine
Published: October 05, 2012
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia.
Journal: Leukemia research
Published: May 15, 2012
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: January 19, 2012
Last Updated: 09/26/2026